Ketek Medication Guide Suggested By FDA Staff
This article was originally published in The Pink Sheet Daily
Executive Summary
Two-day, two-panel advisory committee meeting will consider the risks and benefits of the antibiotic, which Sanofi-Aventis says addresses an unmet medical need.
You may also be interested in...
Replidyne Seeks New Partner For Orapem After Forest Backs Out Of Development
Replidyne said its top priority will be clarifying the regulatory approval process for community antibiotics with FDA.
Replidyne Seeks New Partner For Orapem After Forest Backs Out Of Development
Replidyne said its top priority will be clarifying the regulatory approval process for community antibiotics with FDA.
Grassley Places Hold On Von Eschenbach
The FDA commissioner nominee may have to wait as the senator complains about ignored subpoenas and delayed responses by the agency to committee requests.